The Spanish AI Healthcare Landscape 04/04/2024 Healthcare Access to innovation Rare diseases Personalized medicine While not yet a global player, Artificial Intelligence (AI) is increasingly being integrated into the healthcare... Partners - OWKIN
The Role of Real-World Evidence in the Price and Reimbursement Decisions for Rare Diseases... 02/04/2024 Healthcare Rare diseases Innovative drugs Financing Real-world evidence (RWE) is a promising source of data that could help to accelerate drug access in rare diseases. Partners
Almirall signs licensing agreement with Eloxx Pharmaceuticals and enters the field of rare... 25/03/2024 Healthcare Access to innovation Rare diseases Personalized medicine Advanced therapies The Spanish pharmaceutical company has obtained global rights to develop and commercialize the drug ZKN-013. Partners - Almirall
Sustainable agriculture, new food sources, protection against infectious diseases or waste... 26/03/2024 Healthcare Biosimilars Rare diseases Climate change Agrifood Food & feed Agriculture Biotechnology provides solutions through plant genetic engineering, the revaluation of food industry by-products, new... AseBio
Sustainable agriculture, new food sources, protection against infectious diseases or waste... 25/03/2024 Humanity is at a critical moment for its future, with the need to promote more sustainable economic models that respond... AseBio
AbilityPharma closes €7 million round for metastatic pancreatic cancer drug ABTL0812 11/03/2024 Healthcare Rare diseases Advanced therapies Financing AbilityPharma closes €7 million round to fully fund its international Phase 2b clinical trial with the antitumor drug... Partners - Ability Pharmaceuticals
Spanish researchers to design proteins using AI to make advanced therapies more efficient 04/03/2024 Healthcare Rare diseases Financing The project will be undertaken by a public-private consortium formed by VIVEbiotech, Integra Therapeutics and OneChain... Partners - VIVEbiotech
OneChain Immunotherapeutics has received 1.3M euro grant to advance a new promising CAR T ... 29/02/2024 Healthcare Rare diseases Advanced therapies A consortium led by the Spanish company OneChain Immunotherapeutics has received 1.9M euros from the Spanish Ministry of... Partners - Parc Científic de Barcelona
Biotechnology, crucial in addressing the global challenge posed by rare diseases 29/02/2024 Healthcare Rare diseases Biotechnology is providing answers to rare diseases in areas with unresolved clinical needs such as diagnosis and... AseBio
Biotechnology emerges as a key player in the fight against rare diseases 29/02/2024 In Spain, around three million people live with rare diseases or are in search of a diagnosis. Only 20% of the over 6... AseBio
